Benzinga · Jul 1, 2026
Cantor Fitzgerald Maintains Overweight on Upexi, Lowers Price Target to $1.3
Cantor Fitzgerald analyst Gareth Gacetta maintains Upexi (NASDAQ:UPXI) with a Overweight and lowers the price target from $2 to $1.3.
UP
NASDAQ · UPXI
Upexi, Inc.
Communication Services · Internet Content & Information
$0.93
Up+$0.15 (+15.72%)
Updated Aug 21, 2026, 11:21 PM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 146.33M
- P/E ratio
- 2.45
- Dividend yield
- 0.00%
- 52-week range
- $0.70 – $1.55
- Volume
- 3.63M
- Avg. volume
- 5.06M
Price performance
UPXI price history
1M range · 0 trading sessions · Daily adjusted prices
UPXI does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest UPXI news
The latest Smart Investors Daily articles mentioning UPXI.
Stock researchCompany · Overview
UPXI research
Overview
Company profile and research snapshot.
Company profile
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via Solana. Geographically, the company generates the majority of its revenue from the United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $6.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 1, 2026 | Cantor Fitzgerald | Overweight | — |
| Feb 11, 2026 | Cantor Fitzgerald | Overweight | — |
| Nov 14, 2025 | Cantor Fitzgerald | Overweight | — |
| Feb 15, 2024 | Alliance Global Partners | Neutral | — |
| Aug 15, 2023 | Alliance Global Partners | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Feb 11, 2026
Upexi shares are trading lower after the company reported worse-than-expected Q2 financial results.
Benzinga · Feb 11, 2026
Cantor Fitzgerald Maintains Overweight on Upexi, Lowers Price Target to $2
Cantor Fitzgerald analyst Brett Knoblauch maintains Upexi (NASDAQ:UPXI) with a Overweight and lowers the price target from $6 to $2.
ChartMill · Feb 10, 2026
UPEXI INC (NASDAQ:UPXI) Stock Plummets After Q2 Earnings Miss on Revenue and EPS
UPEXI stock plunges after Q2 earnings miss, with revenue and EPS falling short of analyst estimates despite strong digital asset growth.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
